Simonet, A., Isci, D., Neirinckx, V., Jerusalem, G., & Rogister, B. (06 December 2023). 190P Immune-related roles of B7H3 in glioblastoma [Poster presentation]. ESMO Immuno-oncology. doi:10.1016/j.iotech.2023.100649 |
Sanchez Gil, J., Dubois, M., Neirinckx, V., LOMBARD, A., Coppieters't Wallant, N., D'arrigo, P., Isci, D., Aldenhoff, T., Brouwers, B., Lassence, C., ROGISTER, B., Lebrun, M., & Sadzot, C. (2022). Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: a proof-of-principle. Molecular Therapy: Oncolytics. doi:10.1016/j.omto.2022.06.002 |
Isci, D., Veiga, D., Cokaiko, J., LOMBARD, A., Chevigné, A., ROGISTER, B., & Neirinckx, V. (10 April 2022). Study of the ACKR3/CXCR7 receptor in glioblastoma [Poster presentation]. Télévie Seminar, Liège, Belgium. |
Isci, D.* , D'Uonnolo, G.* , Wantz, M., Rogister, B., LOMBARD, A., Chevigné, A., Szpakowska, M., & Neirinckx, V. (28 December 2021). Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma. Cancers, 14 (1), 130. doi:10.3390/cancers14010130 * These authors have contributed equally to this work. |